Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Research Report 2016-2025
Part 1 Industry Overview
- 1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry
- 1.1.1 Overview
Part 2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Cost Analysis
- 2.1 Industry Chain
- 2.2 Raw Materials
- 2.2.1 Price Trend of Key Raw Materials
Part 3 Market Environment Analysis
- 3.1 SWOT
- 3.2 Market Channel
- 3.3 Downstream Buyers
- 3.4 Economics Analysis
Part 4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment Analysis by Manufacturer
- 4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Capacity and Share by Companies (2016-2019)
- 4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production and Share by Companies (2016-2019)
- 4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Share by Companies (2016-2019)
- 4.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Main Manufacturers Basic Information Analysis
- 4.5 Analysis of the Competitiveness of Mainstream Manufacturers
Part 5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment Analysis by Regions
- 5.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Market by Regions Analysis
- 5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Capacity, Production and Revenue by Regions by Regions (2016-2019)
Part 6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment Analysis by Type
6.1Invokana (Canagliflozin)
- 6.1.1 Overview
- 6.1.2 Invokana (Canagliflozin)Market Analysis
6.2Jardiance (Empagliflozin)
- 6.2.1 Overview
- 6.2.2 Jardiance (Empagliflozin)Market Analysis
6.3Farxiga/Forxiga (Dapagliflozin)
- 6.3.1 Overview
- 6.3.2 Farxiga/Forxiga (Dapagliflozin)Market Analysis
6.4Suglat (Ipragliflozin)
- 6.4.1 Overview
- 6.4.2 Suglat (Ipragliflozin)Market Analysis
Part 7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment Analysis by Application
7.1Hospital
- 7.1.1 Overview
- 7.1.2 HospitalMarket Analysis
7.2Medical Research Institute
- 7.2.1 Overview
- 7.2.2 Medical Research InstituteMarket Analysis
7.3Other
- 7.3.1 Overview
- 7.3.2 OtherMarket Analysis
Part 8 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Analysis
8.1Eli Lilly
- 8.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.1.3 Eli LillySodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.2Janssen Pharmaceuticals
- 8.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.2.3 Janssen PharmaceuticalsSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.3Astellas
- 8.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.3.3 AstellasSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.4Boehringer Ingelheim
- 8.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.4.3 Boehringer IngelheimSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.5AstraZeneca
- 8.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.5.3 AstraZenecaSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.6Bristol Myers Squibb
- 8.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.6.3 Bristol Myers SquibbSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
8.7Kotobuki Pharmaceutical
- 8.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 8.7.2 Sodium/Glucose Cotransporter 2 (SGLT 2) InhibitorsProduct Information
- 8.7.3 Kotobuki PharmaceuticalSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Revenue, Price and Gross Margin (2016-2019)
Part 9 Research Conclusion
This report studies the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market by product type and applications/end industries.
The major players in global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market includes:
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical
Major regions in global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market includes:
China
North America
Europe
Japan
India
Global Other
Major types in global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market includes:
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
Major application in global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market includes:
Hospital
Medical Research Institute
Other